RamakrishnaBattiniMD
Oncology • Germantown, TNGastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer
Oncologist/ Hematologist
Dr. Battini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7945 Wolf River Blvd
Germantown, TN 38138Phone+1 901-683-0055
Summary
- Dr. Ramakrishna Battini is an oncologist in Germantown, TN and is affiliated with Methodist Healthcare Memphis Hospitals. He received his medical degree from Guntur Medical College NTR and has been in practice 14 years. He specializes in gastrointestinal cancer, hematologic oncology, and Lung cancer and is experienced in hematologic oncology, bone marrow transplantation, and general medical oncology. He has 11 publications and over 50 citings.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2009 - 2012- Montefiore Medical Center/Albert Einstein College of Medicine (Wakefield Campus)Residency, Internal Medicine, 2006 - 2009
Guntur Medical College NTRClass of 2002
Certifications & Licensure
MS State Medical License 2017 - 2025
TN State Medical License 2016 - 2025
NY State Medical License 2009 - 2016
OH State Medical License 2012 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 16
- ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Start of enrollment: 2013 Jan 31
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
- Join now to see all
Publications & Presentations
PubMed
- 31 citationsAdult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapyMonica I Zell, Amer Assal, Olga Derman, Noah Kornblum, Ramakrishna Battini
Oncotarget. 2016-06-22 - 32 citationsHigh prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort.Swati Goel, Jeff Hall, Kith Pradhan, Cassandra M. Hirsch, Bartlomiej P Przychodzen
Leukemia. 2016-08-01 - 1 citationsAlectinib-associated pneumoperitoneum in stage IV non-small cell lung cancer - A case report.Renee M Maina, Caroline A Rader, Clarisse S Muenyi, Ramakrishna Battini, Nia N Zalamea
Annals of Medicine and Surgery. 2022-10-01
Press Mentions
Regional One Health Pushes Past 'Trauma-Only' Reputation with Advancements in Cancer TreatmentDecember 30th, 2023
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
